[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100629158":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":24,"locations":24,"responsibleParty":28,"collaborators":30,"id":33,"slug":34,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":24,"eligibilityCriteria":39,"healthyVolunteers":35,"sex":40,"minAge":41,"maxAge":42,"enrollmentInfo":43,"targetDuration":24,"studyType":46,"phases":47,"briefSummary":49,"conditions":50,"keywords":54,"overallStatus":57,"whyStopped":24,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":24},{"fullName":5,"class":6},"Sierra Varona SL","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"fESWT","EXPERIMENTAL","Participants in this arm receive three weekly sessions of focused Extracorporeal Shockwave Therapy (fESWT). The treatment consists of 2,000 pulses per session with an Energy Flux Density (EFD) titrated to patient tolerance (ranging from 0.10 to 0.30 mJ\u002Fmm2) at a frequency of 5-8 Hz.",[13,14],"Device: fESWT","Other: Wait-list Control: Exercise Only",{"label":16,"type":6,"description":17,"interventionNames":18},"Wait-list Control: Exercise Only","Participants in this wait-list control arm perform only the standardized High-Load Strength Training (HLST) program (progressive heel-rises every other day) during the initial 4-week comparative phase. This arm serves as the control group to evaluate the specific clinical and structural added value of fESWT. For ethical reasons, after the primary 4-week assessment is completed, these participants are offered the same fESWT protocol administered to the experimental group.",[14],[20,25],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"DEVICE","Three weekly sessions of focused shockwave therapy. Each session consists of 2,000 pulses at a frequency of 5-8 Hz. The Energy Flux Density (EFD) is titrated between 0.10 and 0.30 mJ\u002Fmm2 based on patient tolerance. The \"point-and-shoot\" technique is applied to the site of maximal tenderness.",[9],null,{"type":6,"name":16,"description":26,"armGroupLabels":27,"otherNames":24},"Participants assigned to this arm will undergo a wait-list period of 4 weeks during which they only perform the standardized High-Load Strength Training (HLST) program. The HLST consists of progressive unilateral heel-rise exercises performed every other day. This group serves as a comparative control to assess the clinical and structural changes (plantar fascia thickness) without the addition of shockwave therapy during the initial phase. After the primary 4-week assessment is completed, participants in this arm are offered the same focused Extracorporeal Shockwave Therapy (fESWT) protocol as the experimental group for ethical reasons.",[16,9],{"type":29,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[31],{"name":32,"class":6},"Universidad Europea de Madrid","100629158","focused-shockwave-therapy-for-plantar-fasciopathy-100629158",false,"NCT07471035","Focused Shockwave Therapy for Plantar Fasciopathy","Focused ESWT vs. Wait-list Management for Plantar Fasciopathy: A Randomized Controlled Trial Evaluating Pain, Function, and Ultrasonographic Plantar Fascia Thickness","Inclusion Criteria:\n\n* Male or female aged between 18 and 70 years. Diagnosis of chronic plantar fasciopathy with symptoms persisting for more than 6 months.\n\nPresence of plantar fascia (PF) thickness \\> 4.0 mm, confirmed by high-resolution ultrasound.\n\nClinical history of localized pain at the medial calcaneal tubercle, specifically upon first steps in the morning or after prolonged rest.\n\nFailure of previous conservative treatments (e.g., stretching, orthotics, or medication).\n\nAbility to follow the High-Load Strength Training (HLST) exercise protocol.\n\nExclusion Criteria:\n\n* Previous treatment with shockwave therapy or corticosteroid injections in the affected foot within the last 6 months.\n\nPrevious surgery for plantar heel pain.\n\nPresence of systemic inflammatory diseases (e.g., rheumatoid arthritis, ankylosing spondylitis).\n\nPregnancy.\n\nCoagulopathies or use of anticoagulant medication.\n\nLocal infection or presence of skin lesions at the application site.\n\nKnown or suspected malignancy in the treatment area.\n\nPresence of neurological conditions or peripheral neuropathy (e.g., tarsal tunnel syndrome).","ALL","18 Years","70 Years",{"count":44,"type":45},20,"ESTIMATED","INTERVENTIONAL",[48],"NA","This study investigates whether focused Extracorporeal Shockwave Therapy (fESWT) helps people with chronic heel pain, commonly known as plantar fasciitis. Many patients suffer from this condition for more than six months without relief.\n\nThe study compares two groups: one receiving fESWT treatment plus a specific exercise program, and a \"wait-list\" group that only performs the exercises at first. The shockwave treatment uses precise sound waves targeted at the painful area to stimulate the body's natural healing process.\n\nResearchers will measure if the treatment reduces pain and improves the patient's ability to walk and perform daily activities. Additionally, ultrasound will be used to see if the thickness of the plantar fascia (the tissue under the foot) decreases and returns to a healthier state. The goal is to confirm if fESWT provides a faster and more effective recovery than exercise alone.",[51,52,53],"Plantar Fascitis","Chronic Plantar Fasciitis","Fasciitis",[55,9,56],"FOCUSED SHOCK WAVE THERAPY","PLANTAR FASCIA THICKNESS","NOT_YET_RECRUITING","2026-03-17",{"date":60,"type":61},"2026-03-20","ACTUAL",{"date":63,"type":45},"2026-04-15",{"date":65,"type":45},"2027-06-30",{"name":5,"class":6}]